|
TOP PAPERS published
in the last two-year plus ten-month period - (fifth bimonthly; 2003-2004 plus Jan-October 31, 2005)
|
 ***Article 1
Total Cites: 193
Article Title: The influence of finasteride on the development of prostate cancer
Authors: Thompson, IM, Goodman, PJ, Tangen, CM, Lucia, MS, Miller, GJ, Ford, LG, Lieber, MM, Cespedes, RD, Atkins, JN, Lippman, SM, Carlin, SM, Ryan, A, Szczepanek, CM, Crowley, JJ, Coltman, CA
Journal: NEW ENGL J MED
Volume: 349
Page: 215-224
Year: 2003
Addresses:
· SW Oncol Grp, Operat Off, San Antonio, TX, USA
· Univ Texas, Hlth Sci Ctr, San Antonio, TX, USA
· NCI, Bethesda, MD, USA
· Mayo Clin, Rochester, MN, USA
· Wilford Hall USAF Med Ctr, San Antonio, TX, USA
· SE Med Oncol Ctr, Goldsboro, NC, USA
· Univ Texas, MD Anderson Canc Ctr, Houston, TX, USA
· Grand Rapids Community Clin Oncol Program, Grand Rapids, MI, USA
· SW Oncol Grp, Ctr Stat, San Antonio, TX, USA
· Univ Colorado, Denver, CO, USA
***Article 2
Total Cites: 101
Article Title: Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
Authors: Harisinghani, MG, Barentsz, J, Hahn, PF, Deserno, WM, Tabatabaei, S, van de Kaa, CH, de la Rosette, J, Weissleder, R
Journal: NEW ENGL J MED
Volume: 348
Page: 2491-U5
Year: 2003
Addresses:
· Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA, USA
· Univ Med Ctr, Nijmegen, Netherlands
***Article 3
Total Cites: 91
Article Title: Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
Authors: Tannock, IF, de Wit, R, Berry, WR, Horti, J, Pluzanska, A, Chi, KN, Oudard, S, Theodore, C, James, ND, Turesson, I, Rosenthal, MA, Eisenberger, MA, Tax 327 Investigators
Journal: NEW ENGL J MED
Volume: 351
Page: 1502-1512
Year: 2004
Addresses:
· Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, Canada
· Univ Toronto, Toronto, Canada
· Erasmus Univ, Med Ctr, Dept Med Oncol, Rotterdam, Netherlands
· Raleigh Hematol Oncol Associates, Cary, NC, USA
· Natl Inst Oncol, Dept Chemotherapy & Clin Pharmacol, Budapest, Hungary
· Med Univ Lodz, Dept Chemotherapy, Lodz, Poland
· British Columbia Canc Agcy, Vancouver, Canada
· Hop Europeen Georges Pompidou, Paris, France
· Inst Gustave Roussy, Villejuif, France
· Canc Res UK Inst Canc Studies, Birmingham, England
· Univ Uppsala Hosp, Sect Oncol, Uppsala, Sweden
· Johns Hopkins Univ, Sydney Kimmel Comprehens Canc Ctr, Baltimore, MD, USA
***Article 4
Total Cites: 91
Article Title: Prevalence of prostate cancer among men with a prostate-specific antigen level <= 4.0 ng per milliliter
Authors: Thompson, IM, Pauler, DK, Goodman, PJ, Tangen, CM, Lucia, MS, Parnes, HL, Minasian, LM, Ford, LG, Lippman, SM, Crawford, ED, Crowley, JJ, Coltman, CA
Journal: NEW ENGL J MED
Volume: 350
Page: 2239-2246
Year: 2004
Addresses:
· SW Oncol Grp SWOG 9217, Operat Off, San Antonio, TX, USA
· Univ Texas, Hlth Sci Ctr, Dept Surg, Div Urol, San Antonio, TX, USA
· Fred Hutchinson Canc Res Ctr, Seattle, WA, USA
· Univ Colorado, Hlth Sci Ctr, Denver, CO, USA
· NCI, Div Canc Prevent, Bethesda, MD, USA
· Univ Texas, MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX, USA
· Canc Res & Biostat, Seattle, WA, USA
***Article 5
Total Cites: 88
Article Title: Prostate cancer epidemiology
Authors: Gronberg, H
Journal: LANCET
Volume: 361
Page: 859-864
Year: 2003
Addresses:
· Umea Univ, Dept Radiat Sci Oncol, Umea, Sweden
***Article 6
Total Cites: 88
Article Title: Mechanisms of disease: Prostate cancer
Authors: Nelson, WG, De Marzo, AM, Isaacs, WB
Journal: NEW ENGL J MED
Volume: 349
Page: 366-381
Year: 2003
Addresses:
· Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Dept Oncol, Baltimore, MD, USA
· Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD, USA
· Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD, USA
***Article 7
Total Cites: 78
Article Title: Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
Authors: Petrylak, DP, Tangen, CM, Hussain, MHA, Lara, PN,J, Jones, JA, Taplin, ME, Burch, PA, Berry, D, Moinpour, C, Kohli, M, Benson, MC, Small, EJ, Raghavan, D, Crawford, ED
Journal: NEW ENGL J MED
Volume: 351
Page: 1513-1520
Year: 2004
Addresses:
· Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY, USA
· SW Oncol Grp, Ctr Stat, Seattle, WA, USA
· Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI, USA
· Univ Calif Davis, Sacramento, CA, USA
· Baylor Coll Med, Houston, TX, USA
· Univ Massachusetts, Med Ctr, Worcester, MA, USA
· Mayo Clin, Rochester, MN, USA
· Univ Washington, Seattle, WA, USA
· Univ Arkansas Med Sci, Little Rock, AR, USA
· Univ Calif San Francisco, Ctr Canc, San Francisco, CA, USA
· Cleveland Clin Fdn, Cleveland, OH, USA
· Univ Colorado, Hlth Sci Ctr, Denver, CO, USA
***Article 8
Total Cites: 72
Article Title: Lead times and overdetection due to prostate-specific antigen screening: Estimates from the European randomized study of screening for prostate cancer
Authors: Draisma, G, Boer, R, Otto, SJ, van der Cruijsen, IW, Damhuis, RAM, Schroder, FH, de Koning, HJ
Journal: J NATL CANCER I
Volume: 95
Page: 868-878
Year: 2003
Addresses:
· Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands
***Article 9
Total Cites: 64
Article Title: Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy
Authors: Damico, AV, Moul, JW, Carroll, PR, Sun, L, Lubeck, D, Chen, MH
Journal: J NATL CANCER I
Volume: 95
Page: 1376-1383
Year: 2003
Addresses:
· Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA, USA
· Dana Farber Canc Inst, Boston, MA, USA
· Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD, USA
· Uniformed Serv Univ Hlth Sci, Urol Serv, Ctr Prostate Dis Res, Bethesda, MD, USA
· Walter Reed Army Med Ctr, Bethesda, MD, USA
· Univ Calif San Francisco, Dept Urol, San Francisco, CA, USA
· Univ Connecticut, Dept Stat, Storrs, CT, USA
***Article 10
Total Cites: 61
Article Title: Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers
Authors: Miller, JC, Zhou, HP, Kwekel, J, Cavallo, R, Burke, J, Butler, EB, Teh, BS, Haab, BB
Journal: PROTEOMICS
Volume: 3
Page: 56-63
Year: 2003
Addresses:
· Van Andel Res Inst, Grand Rapids, MI, USA
· Packard Biochip Technol, Meriden, CT, USA
· Baylor Coll Med, Dept Radiol, Sec Radiat Oncol, Houston, TX, USA
· Methodist Hosp, Houston, TX, USA
***Article 11
Total Cites: 61
Article Title: Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer
Authors: Smith, MR, Eastham, J, Gleason, DM, Shasha, D, Tchekmedyian, S, Zinner, N
Journal: J UROLOGY
Volume: 169
Page: 2008-2012
Year: 2003
Addresses:
· Massachusetts Gen Hosp, Boston, MA, USA
· Overtone Brooks Vet Adm Med Ctr, Shreveport, LA, USA
· Adv Clin Therapeut, Tucson, AZ, USA
· Beth Israel Med Ctr, New York, NY, USA
· Pacific Shores Med Grp, Long Beach, CA, USA
· Western Clin Res, Torrance, CA, USA
***Article 12
Total Cites: 59
Article Title: Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: A randomized, phase II, placebo-controlled trial
Authors: Carducci, MA, Padley, RJ, Breul, J, Vogelzang, NJ, Zonnenberg, BA, Daliani, DD, Schulman, CC, Nabulsi, AA, Humerickhouse, RA, Weinberg, MA, Schmitt, JL, Nelson, JB
Journal: JOURNAL OF CLINICAL ONCOLOGY
Volume: 21
Page: 679-689
Year: 2003
Addresses:
· Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD, USA
· Abbott Labs, Abbott Pk, IL, USA
· Klinikum Rechts Der Isar, Urol Klin & Poliklin, Munich, Germany
· Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL, USA
· Univ Chicago, Ctr Canc Res, Chicago, IL, USA
· Univ Utrecht, Ctr Med, Dept Med Oncol, Utrecht, Netherlands
· Univ Texas, MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX, USA
· Erasme Univ Hosp, Dept Urol, Brussels, Belgium
***Article 13
Total Cites: 59
Article Title: Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen
Authors: Punglia, RS, Damico, AV, Catalona, WJ, Roehl, KA, Kuntz, KM
Journal: NEW ENGL J MED
Volume: 349
Page: 335-342
Year: 2003
Addresses:
· Harvard Univ, Sch Med, Joint Ctr Radiat Therapy, Boston, MA, USA
· Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA, USA
· Dana Farber Canc Inst, Boston, MA, USA
· Washington Univ, Sch Med, Div Urol Surg, St Louis, MO, USA
· Northwestern Univ, Fineberg Sch Med, Dept Urol, Chicago, IL, USA
· Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA, USA
***Article 14
Total Cites: 58
Article Title: Pathological and molecular aspects of prostate cancer
Authors: Demarzo, AM, Nelson, WG, Isaacs, WB, Epstein, JI
Journal: LANCET
Volume: 361
Page: 955-964
Year: 2003
Addresses:
· Johns Hopkins Univ, Sch Med, Johns Hopkins Hosp, Dept Urol, Baltimore, MD, USA
· Johns Hopkins Univ, Sch Med, Johns Hopkins Hosp, Dept Pathol, Baltimore, MD, USA
· Johns Hopkins Univ, Sch Med, Johns Hopkins Hosp, Dept Oncol, Baltimore, MD, USA
· Johns Hopkins Univ, Sch Med, Johns Hopkins Hosp, Dept Med, Baltimore, MD, USA
***Article 15
Total Cites: 56
Article Title: Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer
Authors: Han, M, Partin, AW, Zahurak, M, Piantadosi, S, Epstein, JI, Walsh, PC
Journal: J UROLOGY
Volume: 169
Page: 517-523
Year: 2003
Addresses:
· Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Dept Urol, Baltimore, MD, USA
· Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Dept Oncol, Baltimore, MD, USA
· Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Dept Pathol, Baltimore, MD, USA
***Article 16
Total Cites: 54
Article Title: Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer
Authors: Beer, TM, Eilers, KM, Garzotto, M, Egorin, MJ, Lowe, BA, Henner, WD
Journal: JOURNAL OF CLINICAL ONCOLOGY
Volume: 21
Page: 123-128
Year: 2003
Addresses:
· Oregon Hlth Sci Univ, Dept Med, Portland, OR, USA
· Univ Pittsburgh, Pittsburgh Canc Inst, Pittsburgh, PA, USA
· Vet Adm Med Ctr, Portland, OR, USA
***Article 17
Total Cites: 54
Article Title: Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer
Authors: Rhodes, DR, Sanda, MG, Otte, AP, Chinnaiyan, AM, Rubin, MA
Journal: J NATL CANCER I
Volume: 95
Page: 661-668
Year: 2003
Addresses:
· Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA, USA
· Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI, USA
· Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI, USA
· Univ Amsterdam, Sawmmerdam Inst Life Sci, Dept Biochem, Amsterdam, Netherlands
***Article 18
Total Cites: 52
Article Title: Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
Authors: Wang, SY, Gao, J, Lei, QY, Rozengurt, N, Pritchard, C, Jiao, J, Thomas, GV, Li, G, Roy-burman, P, Nelson, PS, Liu, X, Wu, H
Journal: CANCER CELL
Volume: 4
Page: 209-221
Year: 2003
Addresses:
· Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA, USA
· Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA, USA
· Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA, USA
· Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA, USA
· Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Los Angeles, CA, USA
***Article 19
Total Cites: 51
Article Title: Gene expression profiling identifies clinically relevant subtypes of prostate cancer
Authors: Lapointe, J, Li, C, Higgins, JP, van de Rijn, M, Bair, E, Montgomery, K, Ferrari, M, Egevad, L, Rayford, W, Bergerheim, U, Ekman, P, Demarzo, AM, Tibshirani, R, Botstein, D, Brown, PO, Brooks, JD, Pollack, JR
Journal: P NATL ACAD SCI USA
Volume: 101
Page: 811-816
Year: 2004
Addresses:
· Stanford Univ, Sch Med, Dept Pathol, Stanford, CA, USA
· Stanford Univ, Dept Biochem, Stanford, CA, USA
· Stanford Univ, Dept Urol, Stanford, CA, USA
· Stanford Univ, Dept Stat, Stanford, CA, USA
· Stanford Univ, Dept Hlth Res & Policy, Stanford, CA, USA
· Stanford Univ, Dept Genet, Stanford, CA, USA
· Stanford Univ, Howard Hughes Med Inst, Stanford, CA, USA
· Karolinska Inst, Dept Surg Sci, Urol Sect, Stockholm, Sweden
· Louisiana State Univ, Hlth Sci Ctr, Dept Urol, New Orleans, LA, USA
· Linkoping Univ Hosp, Dept Biomed & Surg, Urol Sect, Linkoping, Sweden
· Johns Hopkins Univ, Dept Pathol, Baltimore, MD, USA
***Article 20
Total Cites: 44
Article Title: Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene
Authors: Edwards, SM, Kote-jarai, Z, Meitz, J, Hamoudi, R, Hope, Q, Osin, P, Jackson, R, Southgate, C, Singh, R, Falconer, A, Dearnaley, DP, Ardern-jones, A, Murkin, A, Dowe, A, Kelly, J, Williams, S, Oram, R, Stevens, M, Teare, DM, Ponder, BAJ, Gayther, SA, Easton, DF, Eeles, RA, Canc Res UK British Prostate Grp U, British Assoc Urological Surg Sect
Journal: AM J HUM GENET
Volume: 72
Page: 38729
Year: 2003
Addresses:
· Inst Canc Res, Translat Canc Genet Team, Sect Canc Genet, Sutton, England
· Inst Canc Res, Mol Genet Team, Sect Canc Genet, Sutton, England
· Royal Marsden Natl Hlth Serv Trust Hosp, Sutton, England
· Univ Coll London, Dept Histopathol, London, England
· Univ Cambridge, Addenbrookes Hosp, Strangeways Res Lab, Canc Res UK Genet Epidemiol Unit, Cambridge, England
· Univ Cambridge, Addenbrookes Hosp, Canc Res UK Human Canc Genet Res Grp, Cambridge, England
|
|
|
